Wells Fargo raised the firm’s price target on Omnicell (OMCL) to $37 from $35 and keeps an Overweight rating on the shares following the company’s improved guidance outlook. While tariff risks remain fluid, the firm believes trade talks will likely steer outcomes toward the lower end of the risk range, supporting a more optimistic stance.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OMCL:
- Omnicell’s Enhanced Profitability and Strategic Initiatives Drive Buy Rating with Increased Price Target
- Omnicell Updates 2025 Guidance and Stock Buyback Plan
- Omnicell announces new $75M share repurchase program
- Omnicell narrows FY25 EPS view to $1.30-$1.65 from $1.00-$1.65
- Omnicell raises Q2 EPS view to 24c-34c from 19c-32c, consensus 25c